Consistent with a previous study (Sotoudeh et al., 2019), our research also revealed that ANTXR1 is an independent prognostic indicator for GC patients and overexpression of ANTXR1 was significantly associated with poor clinical outcomes. Here, ANTXR1 is linked to gastric cancer.